Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Survival of selected patients with ovarian cancer treated with fertility-sparing surgery

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Pregnancy outcomes after recurrent pregnancy loss: a longitudinal cohort study on stress and depression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Investigation of anti-Müllerian hormone concentrations in relation to natural conception rate and time to pregnancy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Luteal phase progesterone and oestradiol after ovarian stimulation: relation to response and prediction of pregnancy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Optimized Biobanking Procedures for Preservation of RNA in Tissue: Comparison of Snap-Freezing and RNAlater-Fixation Methods

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

RESEARCH QUESTION: How many patients in Denmark were treated with fertility-sparing surgery (FSS) for epithelial ovarian cancer (EOC) and what was their prognosis compared with patients treated with radical surgery (RS)?

DESIGN: This study was a retrospective Danish nationwide study, evaluating the effect of FSS compared with RS in patients with EOC, age ≤45 years and International Federation of Gynecology and Obstetrics (FIGO) stage ≤IC3 from 2005 to 2016.

RESULTS: A total of 106 patients were included. Of these, 13 were treated with FSS and 93 were treated with RS. Median age was 27 versus 42 years (P < 0.0001). Overall survival did not differ significantly between the two groups. Overall survival rate in the FSS group was 100%, while the overall survival in the RS group was 87%. Disease-specific survival was 100% in the FSS group and 91% in the RS group.

CONCLUSIONS: This study shows that patients treated with FSS for FIGO stage I EOC do not have an impaired survival compared with patients treated with RS. Nevertheless, the conclusion must be interpreted with caution due to the limited number of patients and the retrospective nature of the study. Larger studies are needed before conclusions can be drawn.

OriginalsprogEngelsk
TidsskriftReproductive BioMedicine Online
Vol/bind37
Udgave nummer1
Sider (fra-til)71-76
Antal sider6
ISSN1472-6483
DOI
StatusUdgivet - jul. 2018

ID: 55852291